CIK 0001192448 · Large accelerated filer
GLAUKOS Corp
Sign in to watch- Ticker
- GKOS
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 949-367-9600
- Business address
- 1 GLAUKOS WAY, ALISO VIEJO, CA, 92656
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $14,953,066
- in 7 filings, $743K under 10b5-1 plans
Net −$14,953,066. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-09 | Burns Thomas William CHAIRMAN & CEO | Option exercise · Stock Option (Right to Buy) | −166,000 | 100,000 | ||
| 2026-02-06 | Burns Thomas William CHAIRMAN & CEO | Gift | −67,353 | 89,621 | ||
| 2026-02-06 | Burns Thomas William CHAIRMAN & CEO | Gift | +67,353 | 961,285 | ||
| 2026-01-22 | Gilliam Joseph E PRESIDENT & COO | Option exercise 10b5-1 | +10,498 | $55.18 | $579K | 102,864 |
| 2026-01-22 | Gilliam Joseph E PRESIDENT & COO | Sale 10b5-1 | −2,406 | $126.10 | $303K | 100,458 |
| 2026-01-22 | Gilliam Joseph E PRESIDENT & COO | Sale 10b5-1 | −3,100 | $127.03 | $394K | 97,358 |
| 2026-01-22 | Gilliam Joseph E PRESIDENT & COO | Sale 10b5-1 | −1,798 | $128.07 | $230K | 95,560 |
| 2026-01-22 | Gilliam Joseph E PRESIDENT & COO | Sale 10b5-1 | −3,194 | $129.28 | $413K | 92,366 |
| 2026-01-22 | Gilliam Joseph E PRESIDENT & COO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,398 | $55.18 | $408K | 55,013 |
| 2026-01-22 | Gilliam Joseph E PRESIDENT & COO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,100 | $55.18 | $171K | 30,713 |
| 2026-01-22 | Stapley Marc Director | Option exercise 10b5-1 | +15,000 | $24.69 | $370K | 52,449 |
| 2026-01-22 | Stapley Marc Director | Sale 10b5-1 | −3,812 | $126.07 | $481K | 48,637 |
| 2026-01-22 | Stapley Marc Director | Sale 10b5-1 | −3,892 | $126.96 | $494K | 44,745 |
| 2026-01-22 | Stapley Marc Director | Sale 10b5-1 | −1,671 | $127.92 | $214K | 43,074 |
| 2026-01-22 | Stapley Marc Director | Sale 10b5-1 | −4,325 | $129.11 | $558K | 38,749 |
| 2026-01-22 | Stapley Marc Director | Sale 10b5-1 | −1,300 | $129.78 | $169K | 37,449 |
| 2026-01-22 | Stapley Marc Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −15,000 | 0 | ||
| 2026-01-21 | Gilliam Joseph E PRESIDENT & COO | Option exercise 10b5-1 | +4,502 | $55.18 | $248K | 96,868 |
| 2026-01-21 | Gilliam Joseph E PRESIDENT & COO | Sale 10b5-1 | −4,502 | $124.65 | $561K | 92,366 |
| 2026-01-21 | Gilliam Joseph E PRESIDENT & COO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,602 | 62,411 |
Page 9 of 12 · 236 trades